documents: FDA-2026-N-0958-0001

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2026-N-0958-0001 FDA FDA-2026-N-0958 Issuance of Priority Review Voucher; Rare Pediatric Disease Product; ZEVASKYN (Prademagene Zamikeracel) Notice Announcement 2026-02-18T05:00:00Z 2026 2     2026-02-18T19:14:39Z 2026-03211 0 0 09000064b91b8ec7

Links from other tables